Endotoxin Contamination in Nanomaterials Leads to the Misinterpretation of Immunosafety Results

by Yang Li, Mayumi Fujita, Diana Boraschi
Published 2017-05-01

A Indústria Têxtil no Brasil: uma perspectiva histórica e cultural

by Mayumi Fujita, Maria José Vicentini Jorente
Published 2015-01-01

A Indústria Têxtil no Brasil: uma perspectiva histórica e cultural

by Mayumi Fujita, Maria José Vicentini Jorente
Published 2015-01-01

Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes

by Jenny Mae Samson, Dinoop Ravindran Menon, Prasanna K. Vaddi, Nazanin Kalani Williams, Joanne Domenico, Zili Zhai, Donald S. Backos, Mayumi Fujita, Mayumi Fujita, Mayumi Fujita
Published 2020-11-01

NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma

by Zili Zhai, Prasanna K. Vaddi, Jenny Mae Samson, Tomoya Takegami, Mayumi Fujita
Published 2021-12-01

Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness

by Mayumi Fujita, Kaori Imadome, Veena Somasundaram, Miki Kawanishi, Kumiko Karasawa, David A. Wink
Published 2020-09-01

Ellagic acid inhibits melanoma growth in vitro

by James Daniel Jensen, Jeffrey H. Dunn, Yuchun Luo, Weimin Liu, Mayumi Fujita, Robert P. Dellavalle
Published 2011-12-01

Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma

by Zili Zhai, Jenny Mae Samson, Takeshi Yamauchi, Prasanna K. Vaddi, Yuko Matsumoto, Charles A. Dinarello, Dinoop Ravindran Menon, Mayumi Fujita
Published 2020-09-01

The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53.

by Steven N Reuland, Nathaniel B Goldstein, Katie A Partyka, David A Cooper, Mayumi Fujita, David A Norris, Yiqun G Shellman
Published 2011-01-01

Strong radioprotective FGF1 signaling down-regulates proliferative and metastatic capabilities of the angiosarcoma cell line, ISOS-1, through the dual inhibition of EGFR and VEGFR...

by Taichi Miura, Mayumi Fujita, Mitsuko Kawano, Kaori Imadome, Takeshi Yasuda, Shoko Nishihara, Toru Imamura, Mikio Masuzawa, Takashi Imai, Fumiaki Nakayama
Published 2017-12-01

The FGF1/CPP-C chimera protein protects against intestinal adverse effects of C-ion radiotherapy without exacerbating pancreatic carcinoma

by Mitsuko Kawano, Taichi Miura, Mayumi Fujita, Sachiko Koike, Kaori Imadome, Atsuko Ishikawa, Takeshi Yasuda, Toru Imamura, Takashi Imai, Fumiaki Nakayama
Published 2019-01-01

Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype

by Mayumi Fujita, Veena Somasundaram, Debashree Basudhar, Robert Y.S. Cheng, Lisa A. Ridnour, Harumi Higuchi, Kaori Imadome, Jae Hong No, Gaurav Bharadwaj, David A. Wink
Published 2019-04-01

ABT-737 synergizes with Bortezomib to kill melanoma cells

by Steven N. Reuland, Nathaniel B. Goldstein, Katie A. Partyka, Shilo Smith, Yuchun Luo, Mayumi Fujita, Rene Gonzalez, Karl Lewis, David A. Norris, Yiqun G. Shellman
Published 2012-02-01

Genetic aberrations in iPSCs are introduced by a transient G1/S cell cycle checkpoint deficiency

by Ryoko Araki, Yuko Hoki, Tomo Suga, Chizuka Obara, Misato Sunayama, Kaori Imadome, Mayumi Fujita, Satoshi Kamimura, Miki Nakamura, Sayaka Wakayama, Andras Nagy, Teruhiko Wakayama, Masumi Abe
Published 2020-01-01

Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma.

by Yuchun Luo, Steven Robinson, Junichi Fujita, Lisa Siconolfi, Jay Magidson, Carl K Edwards, Karl Wassmann, Kathleen Storm, David A Norris, Danute Bankaitis-Davis, William A Robinson, Mayumi Fujita
Published 2011-01-01

FGF18 signaling in the hair cycle resting phase determines radioresistance of hair follicles by arresting hair cycling

by Mitsuko Kawano, PhD, Sachiko Umeda, BS, Takeshi Yasuda, PhD, Mayumi Fujita, PhD, Atsuko Ishikawa, BS, Toru Imamura, PhD, Takashi Imai, PhD, Fumiaki Nakayama, MD, PhD
Published 2016-07-01

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma

by Nabanita Mukherjee, Carol M. Amato, Jenette Skees, Kaleb J. Todd, Karoline A. Lambert, William A. Robinson, Robert Van Gulick, Ryan M. Weight, Chiara R. Dart, Richard P. Tobin, Martin D. McCarter, Mayumi Fujita, David A. Norris, Yiqun G. Shellman
Published 2020-08-01